<p>隨着全球市場在複雜的環境中航行，亞洲經濟體仍然是尋求多樣化機會的投資者的焦點。儘管小盤股通常與較小或新興公司相關聯，但它們仍然提供了引人注目的潛力。通過關注那些財務穩健且增長軌跡明確的公司，這些股票可以在更廣泛的市場中呈現出隱藏的寶藏。</p>
<h3>亞洲十大小盤股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>YKGI (Catalist:YK9)</td>
<td>SGD0.099</td>
<td>SGD42.08M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.14</td>
<td>HK$719.28M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Ever Sunshine Services Group (SEHK:1995)</td>
<td>HK$1.89</td>
<td>HK$3.27B</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.06</td>
<td>HK$1.72B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD0.44</td>
<td>SGD178.33M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Goodbaby International Holdings (SEHK:1086)</td>
<td>HK$1.17</td>
<td>HK$1.95B</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD2.29</td>
<td>SGD9.01B</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Beng Kuang Marine (SGX:BEZ)</td>
<td>SGD0.179</td>
<td>SGD35.66M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>BRC Asia (SGX:BEC)</td>
<td>SGD3.13</td>
<td>SGD858.72M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.39</td>
<td>HK$50.29B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們亞洲小盤股篩選器中的 1,153 只股票的完整列表。</p>
<p>讓我們探索篩選結果中的幾個突出選項。</p>
<h2>Viva Goods (SEHK:933)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Viva Goods Company Limited 是一家投資控股公司，向包括英國、愛爾蘭、美國、中國、亞洲、歐洲、中東和非洲在內的多個地區供應服裝和鞋類，市值為 HK$33.9 億。</p>
<p><strong>運營：</strong> 該公司通過兩個主要部門產生收入：體育體驗，貢獻 HK$5.593 億，以及多品牌服裝和鞋類，貢獻 HK$98.7 億。</p>
<p><strong>市值：</strong> HK$33.9B</p>
<p>Viva Goods Company Limited 的市值為 HK$33.9 億，業務涵蓋多個地區的服裝和鞋類行業。該公司報告 2024 年的收入為 HK$104.3 億，但仍處於虧損狀態，淨虧損為 HK$7041 萬，儘管這比去年有所改善。最近的股票回購公告可能通過提高每股淨資產和每股收益來增強股東價值。儘管面臨虧損，Viva Goods 的現金狀況良好，超過其債務，並有效覆蓋短期和長期負債，資產總額為 HK$50 億，短期負債為 HK$35 億，長期負債為 HK$20 億。</p>
<ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 Viva Goods 的動態。</li>
<li>通過我們的公司歷史業績報告，深入瞭解 Viva Goods 的過去趨勢和表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis"/></p>
<p>SEHK:933 債務與股本歷史及分析截至 2025 年 6 月</p>
<h2>青海春天藥用資源科技 (SHSE:600381)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 青海春天藥用資源科技有限公司在藥用資源領域運營，市值約為 CN¥24.9 億。</p>
<p><strong>運營：</strong> 青海春天藥用資源科技有限公司尚未報告任何具體的收入部門。</p>
<p><strong>市值：</strong> CN¥24.9B</p>
<p>青海春天藥用資源科技的市值為 CN¥24.9 億，儘管近年來處於虧損狀態，但顯示出財務改善的跡象。該公司報告 2025 年第一季度淨收入為 CN¥892 萬，與去年虧損形成對比，2024 年年收入從 CN¥2.1388 億增長至 CN¥2.7026 億。其強勁的現金狀況覆蓋了短期負債（CN¥7090 萬）和長期負債（CN¥290 萬），而無債務的狀態在收益波動和負股本回報率（-15.54%）中增強了財務穩定性。管理層的經驗進一步支持潛在的運營韌性。</p>
<ul>
<li>點擊這裏查看完整的健康分析報告，以更深入瞭解青海春天藥用資源科技。</li>
<li>查看我們的歷史業績報告，以獲取青海春天藥用資源科技的業績記錄的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown"/></p>
<p>SHSE:600381 收入與支出分解截至 2025 年 6 月</p>
<h2>Lecron 工業發展集團 (SZSE:300343)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Lecron 工業發展集團有限公司在工業發展領域運營，市值為 CN¥45.4 億。</p>
<p><strong>運營：</strong> Lecron 工業發展集團有限公司尚未報告任何具體的收入部門。</p>
<p><strong>市值：</strong> CN¥45.4B</p>
<p>Lecron 工業發展集團最近的財務表現表明盈利能力的轉變，2025 年第一季度淨收入為 CN¥502 萬，而去年則出現虧損。儘管這一積極轉變，但公司面臨低股本回報率（2.1%）和負經營現金流等挑戰，這影響了債務覆蓋。然而，其短期資產 CN¥13 億顯著超過負債，為其提供了一定的財務緩衝。該公司還啓動了一項高達 1 億人民幣的股票回購計劃，以支持股權激勵，同時其經驗豐富的管理團隊在高股票波動中提供潛在的穩定性。</p>
<ul>
<li>在這裏深入瞭解樂創工業發展集團的詳細資產負債表健康報告。</li>
<li>通過我們詳細的歷史業績報告評估樂創工業發展集團的過去業績。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis"/></p>
<p>SZSE:300343 財務狀況分析截至 2025 年 6 月</p>
<h2>讓它發生</h2>
<ul>
<li>點擊這裏開始探索其餘的 1,150 只亞洲便士股票。</li>
<li>準備好進入其他投資風格了嗎？探索 22 家在量子計算領域引領革命的頂尖公司，推動下一代技術的發展，並在量子算法、超導量子比特和前沿研究方面取得突破。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

非凡領越

*ST春天

<p>亞洲市場吸引投資者關注有前景的低價股票，儘管存在風險。值得一提的是，非凡領越在服裝和鞋類領域運營，市值為 33.9 億港元，預計 2024 年收入為 104.3 億港元，但淨虧損為 7041 萬港元。青海春天藥用資源科技的估值為 24.9 億人民幣，2025 年第一季度淨收入為 892 萬元，顯示出財務改善。樂創工業發展集團市值為 45.4 億人民幣，已轉向盈利，2025 年第一季度淨收入為 502 萬元。投資者被鼓勵進一步探索這些機會</p>

<p>As global markets navigate a complex landscape, Asian economies remain a focal point for investors seeking diverse opportunities. Penny stocks, often associated with smaller or emerging companies, continue to offer intriguing potential despite their vintage label. By focusing on those with robust financials and clear growth trajectories, these stocks can present hidden gems within the broader market landscape.</p>
<div class="lb-trans"><p>隨着全球市場在複雜的環境中航行，亞洲經濟體仍然是尋求多樣化機會的投資者的焦點。儘管小盤股通常與較小或新興公司相關聯，但它們仍然提供了引人注目的潛力。通過關注那些財務穩健且增長軌跡明確的公司，這些股票可以在更廣泛的市場中呈現出隱藏的寶藏。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亞洲十大小盤股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>YKGI (Catalist:YK9)</td>
<td>SGD0.099</td>
<td>SGD42.08M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.14</td>
<td>HK$719.28M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Ever Sunshine Services Group (SEHK:1995)</td>
<td>HK$1.89</td>
<td>HK$3.27B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.06</td>
<td>HK$1.72B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD0.44</td>
<td>SGD178.33M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Goodbaby International Holdings (SEHK:1086)</td>
<td>HK$1.17</td>
<td>HK$1.95B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD2.29</td>
<td>SGD9.01B</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Beng Kuang Marine (SGX:BEZ)</td>
<td>SGD0.179</td>
<td>SGD35.66M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>BRC Asia (SGX:BEC)</td>
<td>SGD3.13</td>
<td>SGD858.72M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.39</td>
<td>HK$50.29B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>YKGI (Catalist:YK9)</td>
<td>SGD0.099</td>
<td>SGD42.08M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.14</td>
<td>HK$719.28M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Ever Sunshine Services Group (SEHK:1995)</td>
<td>HK$1.89</td>
<td>HK$3.27B</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.06</td>
<td>HK$1.72B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD0.44</td>
<td>SGD178.33M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Goodbaby International Holdings (SEHK:1086)</td>
<td>HK$1.17</td>
<td>HK$1.95B</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD2.29</td>
<td>SGD9.01B</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Beng Kuang Marine (SGX:BEZ)</td>
<td>SGD0.179</td>
<td>SGD35.66M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>BRC Asia (SGX:BEC)</td>
<td>SGD3.13</td>
<td>SGD858.72M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.39</td>
<td>HK$50.29B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 1,153 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們亞洲小盤股篩選器中的 1,153 只股票的完整列表。</p>
</div><p>Let's explore several standout options from the results in the screener.</p>
<div class="lb-trans"><p>讓我們探索篩選結果中的幾個突出選項。</p>
</div><h2>Viva Goods (SEHK:933)</h2>
<div class="lb-trans"><h2>Viva Goods (SEHK:933)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Viva Goods Company Limited is an investment holding company that supplies apparel and footwear across various regions including the United Kingdom, the Republic of Ireland, the United States, China, Asia, Europe, the Middle East, and Africa with a market cap of HK$3.39 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Viva Goods Company Limited 是一家投資控股公司，向包括英國、愛爾蘭、美國、中國、亞洲、歐洲、中東和非洲在內的多個地區供應服裝和鞋類，市值為 HK$33.9 億。</p>
</div><p><strong>Operations:</strong> The company generates revenue through two main segments: Sports Experience, contributing HK$559.30 million, and Multi-Brand Apparel and Footwear, which accounts for HK$9.87 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司通過兩個主要部門產生收入：體育體驗，貢獻 HK$5.593 億，以及多品牌服裝和鞋類，貢獻 HK$98.7 億。</p>
</div><p><strong>Market Cap:</strong> HK$3.39B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$33.9B</p>
</div><p>Viva Goods Company Limited, with a market cap of HK$3.39 billion, operates in the apparel and footwear sectors across various regions. The company reported revenues of HK$10.43 billion for 2024 but remains unprofitable with a net loss of HK$70.41 million, though this is an improvement from the previous year. Recent share repurchase announcements could enhance shareholder value by increasing net asset value per share and earnings per share. Despite its losses, Viva Goods has a strong cash position exceeding its debt and covers both short-term and long-term liabilities effectively with assets totaling HK$5 billion against liabilities of HK$3.5 billion short-term and HK$2 billion long-term.</p>
<div class="lb-trans"><p>Viva Goods Company Limited 的市值為 HK$33.9 億，業務涵蓋多個地區的服裝和鞋類行業。該公司報告 2024 年的收入為 HK$104.3 億，但仍處於虧損狀態，淨虧損為 HK$7041 萬，儘管這比去年有所改善。最近的股票回購公告可能通過提高每股淨資產和每股收益來增強股東價值。儘管面臨虧損，Viva Goods 的現金狀況良好，超過其債務，並有效覆蓋短期和長期負債，資產總額為 HK$50 億，短期負債為 HK$35 億，長期負債為 HK$20 億。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Viva Goods.</li>
<li>Gain insights into Viva Goods' past trends and performance with our report on the company's historical track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 Viva Goods 的動態。</li>
<li>通過我們的公司歷史業績報告，深入瞭解 Viva Goods 的過去趨勢和表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis"/></p>
<p>SEHK:933 Debt to Equity History and Analysis as at Jun 2025</p>
<div class="lb-trans"><p>SEHK:933 債務與股本歷史及分析截至 2025 年 6 月</p>
</div><h2>Qinghai Spring Medicinal Resources Technology (SHSE:600381)</h2>
<div class="lb-trans"><h2>青海春天藥用資源科技 (SHSE:600381)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥2.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 青海春天藥用資源科技有限公司在藥用資源領域運營，市值約為 CN¥24.9 億。</p>
</div><p><strong>Operations:</strong> Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>運營：</strong> 青海春天藥用資源科技有限公司尚未報告任何具體的收入部門。</p>
</div><p><strong>Market Cap:</strong> CN¥2.49B</p>
<div class="lb-trans"><p><strong>市值：</strong> CN¥24.9B</p>
</div><p>Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥2.49 billion, shows signs of financial improvement despite its unprofitable status over recent years. The company reported a net income of CN¥8.92 million for Q1 2025, contrasting with a loss the previous year, and annual revenue growth from CN¥213.88 million to CN¥270.26 million in 2024. Its strong cash position covers both short-term liabilities (CN¥70.9M) and long-term liabilities (CN¥2.9M), while remaining debt-free enhances financial stability amidst volatility in earnings and negative return on equity (-15.54%). Management's experience further supports potential operational resilience.</p>
<div class="lb-trans"><p>青海春天藥用資源科技的市值為 CN¥24.9 億，儘管近年來處於虧損狀態，但顯示出財務改善的跡象。該公司報告 2025 年第一季度淨收入為 CN¥892 萬，與去年虧損形成對比，2024 年年收入從 CN¥2.1388 億增長至 CN¥2.7026 億。其強勁的現金狀況覆蓋了短期負債（CN¥7090 萬）和長期負債（CN¥290 萬），而無債務的狀態在收益波動和負股本回報率（-15.54%）中增強了財務穩定性。管理層的經驗進一步支持潛在的運營韌性。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Qinghai Spring Medicinal Resources Technology.</li>
<li>Review our historical performance report to gain insights into Qinghai Spring Medicinal Resources Technology's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏查看完整的健康分析報告，以更深入瞭解青海春天藥用資源科技。</li>
<li>查看我們的歷史業績報告，以獲取青海春天藥用資源科技的業績記錄的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown"/></p>
<p>SHSE:600381 Revenue &amp; Expenses Breakdown as at Jun 2025</p>
<div class="lb-trans"><p>SHSE:600381 收入與支出分解截至 2025 年 6 月</p>
</div><h2>Lecron Industrial Development Group (SZSE:300343)</h2>
<div class="lb-trans"><h2>Lecron 工業發展集團 (SZSE:300343)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Lecron Industrial Development Group Co., Ltd. operates in the industrial development sector and has a market cap of CN¥4.54 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Lecron 工業發展集團有限公司在工業發展領域運營，市值為 CN¥45.4 億。</p>
</div><p><strong>Operations:</strong> Lecron Industrial Development Group Co., Ltd. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>運營：</strong> Lecron 工業發展集團有限公司尚未報告任何具體的收入部門。</p>
</div><p><strong>Market Cap:</strong> CN¥4.54B</p>
<div class="lb-trans"><p><strong>市值：</strong> CN¥45.4B</p>
</div><p>Lecron Industrial Development Group's recent financial performance indicates a shift to profitability, with Q1 2025 net income at CN¥5.02 million compared to a loss the previous year. Despite this positive turn, the company faces challenges like low return on equity (2.1%) and negative operating cash flow, which impacts debt coverage. However, its short-term assets of CN¥1.3 billion significantly exceed liabilities, providing some financial cushion. The company has also initiated a share buyback program worth up to CN¥100 million to support equity incentives, while its experienced management team offers potential stability amidst high stock volatility.</p>
<div class="lb-trans"><p>Lecron 工業發展集團最近的財務表現表明盈利能力的轉變，2025 年第一季度淨收入為 CN¥502 萬，而去年則出現虧損。儘管這一積極轉變，但公司面臨低股本回報率（2.1%）和負經營現金流等挑戰，這影響了債務覆蓋。然而，其短期資產 CN¥13 億顯著超過負債，為其提供了一定的財務緩衝。該公司還啓動了一項高達 1 億人民幣的股票回購計劃，以支持股權激勵，同時其經驗豐富的管理團隊在高股票波動中提供潛在的穩定性。</p>
</div><ul>
<li>Dive into the specifics of Lecron Industrial Development Group here with our thorough balance sheet health report.</li>
<li>Assess Lecron Industrial Development Group's previous results with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏深入瞭解樂創工業發展集團的詳細資產負債表健康報告。</li>
<li>通過我們詳細的歷史業績報告評估樂創工業發展集團的過去業績。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis"/></p>
<p>SZSE:300343 Financial Position Analysis as at Jun 2025</p>
<div class="lb-trans"><p>SZSE:300343 財務狀況分析截至 2025 年 6 月</p>
</div><h2>Make It Happen</h2>
<div class="lb-trans"><h2>讓它發生</h2>
</div><ul>
<li>Click through to start exploring the rest of the 1,150 Asian Penny Stocks now.</li>
<li>Ready To Venture Into Other Investment Styles? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏開始探索其餘的 1,150 只亞洲便士股票。</li>
<li>準備好進入其他投資風格了嗎？探索 22 家在量子計算領域引領革命的頂尖公司，推動下一代技術的發展，並在量子算法、超導量子比特和前沿研究方面取得突破。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

亞洲市場洞察：非凡領越及其他兩隻知名便士股